BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, April 18, 2026
Home » Topics » Science

Science
Science RSS Feed RSS

New PCa treatment strategy may overcome resistance

Dec. 6, 2019
By John Fox
Targeting prostate cancer (PCa) neuroendocrine (NE) cells via inhibition of the C-X-C motif chemokine receptor 2 (CXCR2) is an androgen receptor (AR)-independent therapeutic strategy that can improve the efficacy of treatment for PCa, a leading cause of male cancer mortality.
Read More

Bioworld MedTech’s Neurology Extra for Dec. 6, 2019

Dec. 6, 2019
By Andrea Applegate
Keeping you up to date on recent developments in neurology.
Read More

Bioworld MedTech’s Diagnostics Extra for Dec. 5, 2019

Dec. 5, 2019
By Meg Bryant and Anette Breindl
Keeping you up to date on recent developments in diagnostics.
Read More

Bioworld MedTech’s Orthopedics Extra for Dec. 4, 2019

Dec. 4, 2019
By Holland Johnson
Keeping you up to date on recent developments in orthopedics.
Read More

Bioworld MedTech’s Oncology Extra for Dec. 3, 2019

Dec. 3, 2019
By Mark McCarty
Keeping you up to date on recent developments in oncology.
Read More
‘Absolutely fascinating’

Stem cells, dead cells work equally well for heart repair

Dec. 2, 2019
By Anette Breindl
A study published in the Nov. 27, 2019, advance online issue of Nature manages a rare feat. It is both a vindication of and egg in the face for cardiac stem cell research.
Read More
Blue puzzle pieces, red ribbon
World AIDS Day

Immediate ART initiation for neonates with HIV-1 provides significant results

Dec. 2, 2019
By Nuala Moran
LONDON – Initiating antiretroviral treatment (ART) as soon as infants who are positive for HIV-1 infection are born has significant protective effects, with fewer viral reservoir cells and improved immune system development, according to new research.
Read More

Bioworld MedTech’s Cardiology Extra

Dec. 2, 2019
By Liz Hollis and Anette Breindl
Keeping you up to date on recent developments in cardiology.
Read More
Petri dish and capsules
There’s an app for THAT?!

Web-based tool facilitates new antibiotic development

Nov. 27, 2019
By John Fox
A new web-based tool allowing rapid in silico prediction of the ability of candidate antibiotics to accumulate in Gram-negative bacteria should enable subsequent prioritization of new compounds for synthesis and further evaluation, U.S. researchers reported Nov. 18, 2019, in Nature Microbiology.
Read More
‘Absolutely fascinating’

Stem cells, dead cells work equally well for heart repair

Nov. 27, 2019
By Anette Breindl
A study published in the Nov. 27, 2019, advance online issue of Nature manages a rare feat. It is both a vindication of and egg in the face for cardiac stem cell research. The good news is that cardiac stem cell transplantation after a heart attack does improve heart function, although the effect is “mild,” Jeffery Molkentin told BioWorld.
Read More
Previous 1 2 … 178 179 180 181 182 183 184 185 186 … 194 195 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 17, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 14, 2026
  • Elderly woman holding illustration of brain with missing puzzle piece

    Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’

    BioWorld
    The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
  • Cancer cell in the cross-hairs

    Selective CBL-B inhibitor with improved safety profile disclosed

    BioWorld Science
    CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
  • MSD discloses new HCN1/2 blockers

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing